Cardiac Dysfunction Among Ugandan HIV-infected Children on Antiretroviral Therapy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26569195)

Published in Pediatr Infect Dis J on March 01, 2016

Authors

Judith Namuyonga1, Sulaiman Lubega, Victor Musiime, Peter Lwabi, Irene Lubega

Author Affiliations

1: From the *Department of Paediatrics, Makerere University College of Health Sciences; †Pediatric Cardiology Department, Uganda Heart Institute, Mulago Hospital; ‡Directorate of Research and Grants, Joint Clinical Research Centre (JCRC); and §Clinic Department, Makerere University-John Hopkins University (MUJHU) Care Limited, Kampala, Uganda.

Articles cited by this

Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation (2012) 5.33

Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis (2008) 4.80

Pericardial effusion in AIDS. Incidence and survival. Circulation (1995) 3.22

World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol (2012) 2.75

Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics (2007) 2.24

Cardiac morbidity and related mortality in children with HIV infection. JAMA (1993) 1.65

Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol (1989) 1.33

Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication. Clin Infect Dis (2001) 1.21

Heart disease among children with HIV/AIDS attending the paediatric infectious disease clinic at Mulago Hospital. Afr Health Sci (2005) 1.13

Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndrome. J Am Coll Cardiol (2003) 1.12

QTc interval prolongation in patients with HIV and AIDS. J Natl Med Assoc (2005) 1.09

HIV infection, highly active antiretroviral therapy and the cardiovascular system. Cardiovasc Res (2003) 1.01

Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study. Am Heart J (2003) 1.01

Cardiovascular dysfunction in HIV-infected children in a sub-Saharan African country: comparative cross-sectional observational study. J Trop Pediatr (2011) 1.01

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations. AIDS (2011) 0.91

AIDS in childhood: cardiac involvement with and without triple combination antiretroviral therapy. Arq Bras Cardiol (2008) 0.89

Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen. Clin Infect Dis (2003) 0.89

Articles by these authors

Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation (2012) 5.33

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet (2013) 2.61

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS Med (2013) 1.19

Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection. Pediatr Cardiol (2014) 1.15

Cardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda. Cardiovasc J Afr (2013) 1.14

Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy. Pediatr Infect Dis J (2011) 1.05

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study. AIDS Res Treat (2012) 0.97

The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children. AIDS (2010) 0.96

Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic. AIDS Res Ther (2013) 0.95

Management of rheumatic heart disease in uganda: the emerging epidemic of non-AIDS comorbidity in resource-limited settings. J Acquir Immune Defic Syndr (2014) 0.89

Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda. PLoS One (2012) 0.88

Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods: a prospective cohort study. Paediatr Drugs (2012) 0.88

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy. Pediatr Infect Dis J (2015) 0.83

Psychosocial challenges and strategies for coping with HIV among adolescents in Uganda: a qualitative study. AIDS Patient Care STDS (2015) 0.82

Recent advances in pharmacovigilance of antiretroviral therapy in HIV-infected and exposed children. Curr Opin HIV AIDS (2012) 0.82

Pubertal development in HIV-infected African children on first-line antiretroviral therapy. AIDS (2015) 0.82

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe. AIDS Res Hum Retroviruses (2014) 0.81

Dried blood spots on filter paper as an alternative specimen for measles diagnostics: detection of measles immunoglobulin M antibody by a commercial enzyme immunoassay. J Infect Dis (2011) 0.81

Disclosure of HIV Status to Perinatally Infected Adolescents in Urban Uganda: A Qualitative Study on Timing, Process, and Outcomes. J Assoc Nurses AIDS Care (2015) 0.81

Distribution of haematological and chemical pathology values among infants in Malawi and Uganda. Paediatr Int Child Health (2012) 0.81

A Case of Cryptococcal Lymphadenitis in an HIV-Infected Child. AIDS Res Hum Retroviruses (2010) 0.80

Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy. AIDS Res Hum Retroviruses (2013) 0.80

Development of a psychosocial distress measure for Ugandan adolescents living with HIV. AIDS Behav (2015) 0.79

Opportunities for improving the efficiency of paediatric HIV treatment programmes. AIDS (2015) 0.79

Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults. Chemother Res Pract (2011) 0.79

Need for review of prevention of mother-to-child transmission practice especially in discordant couples: a case of mother-to-child transmission of HIV during breast feeding by a mother who tested HIV negative antenatally. AIDS (2007) 0.77

Does the CHER trial open up new therapeutic perspectives? Lancet (2013) 0.75

Brief Report: Prevalence of Latent Rheumatic Heart Disease Among HIV-Infected Children in Kampala, Uganda. J Acquir Immune Defic Syndr (2016) 0.75

Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda. AIDS (2017) 0.75

Virologic Response to First-Line Efavirenz- or Nevirapine-Based Anti-Retroviral Therapy in HIV-Infected African Children. Pediatr Infect Dis J (2016) 0.75

Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children. Pediatr Infect Dis J (2017) 0.75

Insulin Resistance and Markers of Inflammation in HIV-Infected Ugandan Children in the CHAPAS 3 Trial. Pediatr Infect Dis J (2017) 0.75